Reservoir-Less Ports for Hepatic Arterial Infusion

Yael Berger; Gali Perl; Eran Sadot

doi:10.1007/978-3-031-74935-3_33

Reservoir-Less Ports for Hepatic Arterial Infusion

Yael Berger, Gali Perl, Eran Sadot^*

^*Corresponding author for this work

Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Hepatic artery infusion (HAI) is a locoregional treatment for liver tumors that delivers high-dose chemotherapy directly to the liver. This chapter focuses on reservoir-less ports for HAI, a technique that utilizes different chemotherapeutic agents compared to traditional HAI systems with pumps. The rationale for reservoir-less HAI, drugs used, and implantation techniques with both surgical and percutaneous approaches are described. Additionally, potential complications are addressed. The chapter concludes by discussing the application of reservoir-less port HAI for treatment of colorectal liver metastases (CRLM) and hepatocellular carcinoma (HCC). Studies have shown promising results for HAI with oxaliplatin for CRLM and HAI with FOLFOX for HCC, offering an alternative treatment option for these patients.

Original language	English
Title of host publication	Hepatic Arterial Infusion for Malignancy
Publisher	Springer Science+Business Media
Pages	337-351
Number of pages	15
ISBN (Electronic)	9783031749353
ISBN (Print)	9783031749346
DOIs	https://doi.org/10.1007/978-3-031-74935-3_33
State	Published - 1 Jan 2025

Keywords

Chemotherapy
Colorectal liver metastases (CRLM)
FOLFOX
Hepatic artery infusion (HAI)
Hepatocellular carcinoma (HCC)
Oxaliplatin
Reservoir-less port

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-031-74935-3_33

Cite this

@inbook{c134c935f7bd43818a84dddeaae8e1b4,

title = "Reservoir-Less Ports for Hepatic Arterial Infusion",

abstract = "Hepatic artery infusion (HAI) is a locoregional treatment for liver tumors that delivers high-dose chemotherapy directly to the liver. This chapter focuses on reservoir-less ports for HAI, a technique that utilizes different chemotherapeutic agents compared to traditional HAI systems with pumps. The rationale for reservoir-less HAI, drugs used, and implantation techniques with both surgical and percutaneous approaches are described. Additionally, potential complications are addressed. The chapter concludes by discussing the application of reservoir-less port HAI for treatment of colorectal liver metastases (CRLM) and hepatocellular carcinoma (HCC). Studies have shown promising results for HAI with oxaliplatin for CRLM and HAI with FOLFOX for HCC, offering an alternative treatment option for these patients.",

keywords = "Chemotherapy, Colorectal liver metastases (CRLM), FOLFOX, Hepatic artery infusion (HAI), Hepatocellular carcinoma (HCC), Oxaliplatin, Reservoir-less port",

author = "Yael Berger and Gali Perl and Eran Sadot",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2025.",

year = "2025",

month = jan,

day = "1",

doi = "10.1007/978-3-031-74935-3_33",

language = "אנגלית",

isbn = "9783031749346",

pages = "337--351",

booktitle = "Hepatic Arterial Infusion for Malignancy",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Reservoir-Less Ports for Hepatic Arterial Infusion

AU - Berger, Yael

AU - Perl, Gali

AU - Sadot, Eran

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2025.

PY - 2025/1/1

Y1 - 2025/1/1

N2 - Hepatic artery infusion (HAI) is a locoregional treatment for liver tumors that delivers high-dose chemotherapy directly to the liver. This chapter focuses on reservoir-less ports for HAI, a technique that utilizes different chemotherapeutic agents compared to traditional HAI systems with pumps. The rationale for reservoir-less HAI, drugs used, and implantation techniques with both surgical and percutaneous approaches are described. Additionally, potential complications are addressed. The chapter concludes by discussing the application of reservoir-less port HAI for treatment of colorectal liver metastases (CRLM) and hepatocellular carcinoma (HCC). Studies have shown promising results for HAI with oxaliplatin for CRLM and HAI with FOLFOX for HCC, offering an alternative treatment option for these patients.

AB - Hepatic artery infusion (HAI) is a locoregional treatment for liver tumors that delivers high-dose chemotherapy directly to the liver. This chapter focuses on reservoir-less ports for HAI, a technique that utilizes different chemotherapeutic agents compared to traditional HAI systems with pumps. The rationale for reservoir-less HAI, drugs used, and implantation techniques with both surgical and percutaneous approaches are described. Additionally, potential complications are addressed. The chapter concludes by discussing the application of reservoir-less port HAI for treatment of colorectal liver metastases (CRLM) and hepatocellular carcinoma (HCC). Studies have shown promising results for HAI with oxaliplatin for CRLM and HAI with FOLFOX for HCC, offering an alternative treatment option for these patients.

KW - Chemotherapy

KW - Colorectal liver metastases (CRLM)

KW - FOLFOX

KW - Hepatic artery infusion (HAI)

KW - Hepatocellular carcinoma (HCC)

KW - Oxaliplatin

KW - Reservoir-less port

UR - http://www.scopus.com/inward/record.url?scp=105008169138&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-74935-3_33

DO - 10.1007/978-3-031-74935-3_33

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:105008169138

SN - 9783031749346

SP - 337

EP - 351

BT - Hepatic Arterial Infusion for Malignancy

PB - Springer Science+Business Media

ER -

Reservoir-Less Ports for Hepatic Arterial Infusion

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this